6918 — A Plus Biotechnology Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual balance sheet for A Plus Biotechnology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	306	239	320	392	609
Net Total Accounts Receivable
Net Total Receivables	136	150	144	185	179
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	761	714	770	897	1,187
Net Property, Plant And Equipment	233	260	259	252	244
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,206	1,175	1,114	1,177	1,550
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	203	174	143	163	198
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	362	297	243	258	287
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	844	878	870	919	1,263
Total Liabilities & Shareholders' Equity	1,206	1,175	1,114	1,177	1,550
Total Common Shares Outstanding